Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.
breast
diagnosis
ductal carcinoma in situ
needle core biopsy
vacuum-assisted biopsy
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
revised:
25
05
2023
received:
04
01
2023
accepted:
01
06
2023
medline:
11
8
2023
pubmed:
26
6
2023
entrez:
25
6
2023
Statut:
ppublish
Résumé
The method of diagnosis of ductal carcinoma in situ (DCIS) has changed since the 1980s. The aim of this audit was to assess changes in the preoperative diagnosis of DCIS since the introduction of needle core biopsy, particularly the proportion with a preoperative biopsy diagnosis of DCIS. The preoperative diagnoses of patients with a final diagnosis of DCIS in the surgical specimen were reviewed (i) in 809 patients who presented through breast screening from 1997 to 2021, and (ii) in all patients in 5 individual years at 5-year intervals from 2000 to 2020 (254 in total). For screening-detected DCIS the proportion with a preoperative diagnosis of DCIS increased from 75% to 98% over the study period. In a detailed analysis of all cases of DCIS in 5 separate years the proportion with a preoperative diagnosis of DCIS increased from 68% in 2000 to 96% in 2020. For high-grade DCIS the proportion increased from 87% to 97%, and for low- or intermediate-grade DCIS from 48% to 93%. The proportion of women who had vacuum-assisted biopsy increased from 7% in 2000 to 58% in 2015. There was a small increase in the number of biopsies that had basal cytokeratin and oestrogen receptor immunohistochemistry to aid diagnosis. There has been an increase in the preoperative diagnosis of DCIS, particularly of low- or intermediate-grade, over the last two decades. The increasing use of vacuum-assisted biopsy is likely to be a major contributory factor to this increase.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
435-442Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
van Steenbergen LN, Voogd AC, Roukema JA et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res. Treat. 2009; 115; 181-183.
Brennan ME, Turner RM, Ciatto S et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011; 260; 119-228.
Giannotti E, James JJ, Chen Y et al. Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy. Eur. Radiol. 2021; 31; 9540-9547.
Non-Operative Diagnosis Working Group of the UK National Coordinating Committee for Breast Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. London: The Royal College of Pathologists, 2021.
Non-operative Diagnosis Subgroup of the National Coordinating Committee for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. London: The Royal College of Pathologists, 2016.
NHS Breast screening programme screening standards valid for data collected from 1 April 2021. Public Health England, 2021. https://www.gov.uk/government/publications/breast-screening-consolidated-programme-standards/nhs-breast-screening-programme-screening-standards-valid-for-data-collected-from-1-april-2021.
Glynn CG, Farria DM, Monsees BS, Salcman JT, Wiele KN, Hildebolt CF. Effect of transition to digital mammography on clinical outcomes. Radiology 2011; 260; 664-670.
Huang XC, Hu XH, Wang XR et al. A comparison of diagnostic performance of vacuum-assisted biopsy and core needle biopsy for breast microcalcification: a systematic review and meta-analysis. Ir. J. Med. Sci. 2018; 187; 999-1008.
Sohn V, Arthurs Z, Herbert G et al. Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle. Ann. Surg. Oncol. 2007; 14; 2497-2450.
Rosenfield Darling ML, Smith DN, Lester SC et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am. J. Roentgenol. 2000; 175; 1341-1346.
Shaaban AM, Hilton B, Clements K et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project. Br. J. Cancer 2021; 124; 1009-1017.
Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES. Incidence of ductal carcinoma in situ in the United States, 2000-2014. Cancer Epidemiol. Biomarkers Prev. 2019; 28; 1316-1323.
NHS Breast Screening Programme. Clinical guidance for breast cancer screening assessment. London: NHSBSP Publication no. 49. 4th ed, 2016. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/465694/nhsbsp20.pdf.
Strachan C, Horgan K, Millican-Slater RA, Shaaban AM, Sharma N. Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice? J. Clin. Pathol. 2016; 69; 248-254.
Rakha EA, Ho BC, Naik V et al. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology 2011; 58; 626-632.
El-Sayed ME, Rakha EA, Reed J, Lee AHS, Evans AJ, Ellis IO. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur. J. Cancer 2008; 44; 2580-2586.
Breast screening pathology audit for the screening period April 2016 to March 2019. Public Health England, 2020. https://www.gov.uk/government/publications/national-breast-screening-pathology-audit.
Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2007; 37; 232-240.
Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J. Pathol. 1999; 188; 237-244.
Lamb J, Anderson TJ. Influence of cancer histology on the success of fine needle aspiration of the breast. J. Clin. Pathol. 1989; 42; 733-735.
Wilson R, Liston J. Clinical guidelines for breast cancer screening assessment. 2nd ed. NHS Cancer Screening Programmes: Sheffield, 2005.
Liston J, Wilson R. Clinical guidelines for breast cancer screening assessment. 3rd ed. Sheffield: NHS Cancer Screening Programmes, 2010.